FOGHORN Canadian Trademark Information

On Friday, January 18, 2019, a canadian trademark registration was filed for FOGHORN by Foghorn Therapeutics Inc. *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1941647. The current status of this trademark filing is Registration published. The FOGHORN trademark is filed in the description of Agents for scientific and research use, namely, pharmaceutical agents that modulate epigenetic mechanisms to treat disease for use in the field of biotechnology; chemical agents for use in the research, discovery and development of pharmaceuticals and research on epigenetic structures and functions; reagents for scientific and medical research use , Agents for scientific and research use, namely, pharmaceutical agents that modulate epigenetic mechanisms to treat disease for use in the field of biotechnology; chemical agents for use in the research, testing, and development of pharmaceuticals and research on epigenetic structures and functions; cell culture reagents for scientific and medical research use. , Agents for scientific and research use, namely, pharmaceutical agents that modulate epigenetic mechanisms to treat disease for use in the field of biotechnology; chemical agents for use in the research, discovery and development of pharmaceuticals and research on epigenetic structures and functions; reagents for scientific and medical research use , Agents for medical and veterinary use, namely, pharmaceutical preparations for the treatment of diseases and disorders, namely, oncological, neurological, developmental, hematological, bone, respiratory, central nervous system, endrocrinological, metabolic, circulatory, gastroenterological, hormonal and diabetic disorders; pharmaceuticals, namely, epigenetic modulating agents and chromatin regulating agents to treat disease; diagnostic agents, preparations and substances for medical purposes , Agents for medical and veterinary use, namely, pharmaceutical preparations for the treatment of diseases and disorders, namely, oncological, neurological, developmental, hematological, bone, respiratory, central nervous system, endrocrinological, metabolic, circulatory, gastroenterological, hormonal and diabetic disorders; pharmaceuticals, namely, epigenetic modulating agents and chromatin regulating agents to treat disease; diagnostic agents, preparations and substances for medical purposes , Agents for medical and veterinary use, namely, pharmaceutical preparations for the treatment of diseases and disorders, namely, oncological, neurological, hematological, bone, respiratory, central nervous system, endocrinological, metabolic, circulatory, gastroenterological, hormonal and diabetic disorders; pharmaceuticals, namely, epigenetic modulating agents and chromatin regulating agents to treat disease; clinical diagnostic reagents, preparations and substances for medical purposes; diagnostic chemical reagents for medical purposes , Agents for medical and veterinary use, namely, pharmaceutical preparations for the treatment of diseases and disorders, namely, oncological, neurological, developmental, hematological, bone, respiratory, central nervous system, endrocrinological, metabolic, circulatory, gastroenterological, hormonal and diabetic disorders; pharmaceuticals, namely, epigenetic modulating agents and chromatin regulating agents to treat disease; diagnostic agents, preparations and substances for medical purposes .